# IMMUCOR INC

IMMUCOR INC is a company headquartered in Norcross, GA, United States.

## Company overview

- **Legal name:** IMMUCOR INC
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Norcross, GA, United States
- **Incorporated in:** GA
- **Fiscal year end:** May 31
- **SEC CIK:** 0000736822

## About

IMMUCOR INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000736822, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2016-08-22, it reported annual revenue of USD 379,972,000; net income of USD -42,090,000; total assets of USD 1,707,633,000 for the fiscal period ended 2016-05-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-05-31)

- **Revenue:** $380.0M (USD 379,972,000)
- **Net income:** -$42.1M (USD -42,090,000)
- **Total assets:** $1.7B (USD 1,707,633,000)
- **Cash and equivalents:** $10.3M (USD 10,263,000)

### FY2015 (period ended 2015-05-31)

- **Revenue:** $389.3M (USD 389,300,000)
- **Net income:** -$60.7M (USD -60,725,000)
- **Total assets:** $1.8B (USD 1,752,686,000)
- **Cash and equivalents:** $18.4M (USD 18,363,000)
- **Operating cash flow:** $25.6M (USD 25,590,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-05-31)

- **Revenue:** $388.1M (USD 388,056,000)
- **Net income:** -$182.3M (USD -182,257,000)
- **Total assets:** $1.8B (USD 1,824,414,000)
- **Cash and equivalents:** $23.6M (USD 23,621,000)
- **Operating cash flow:** $25.6M (USD 25,601,000)

### FY2013 (period ended 2013-05-31)

- **Revenue:** $347.8M (USD 347,788,000)
- **Net income:** -$39.1M (USD -39,142,000)
- **Total assets:** $2.0B (USD 2,000,970,000)
- **Cash and equivalents:** $29.4M (USD 29,388,000)
- **Operating cash flow:** $24.5M (USD 24,534,000)

## Recent SEC filings

- Form 8-K — filed 2017-07-18 — period 2017-07-18 — FORM 8-K
- Form 8-K — filed 2017-06-23 — period 2017-06-23 — FORM 8-K
- Form 8-K — filed 2017-06-21 — period 2017-06-21 — FORM 8-K
- Form 8-K — filed 2017-06-20 — period 2017-06-19 — FORM 8-K
- Form 8-K — filed 2017-04-19 — period 2017-04-18 — FORM 8-K
- Form 10-Q — filed 2017-04-11 — period 2017-02-28 — FORM 10-Q
- Form 10-Q — filed 2017-01-17 — period 2016-11-30 — FORM 10-Q
- Form 10-Q — filed 2016-10-17 — period 2016-08-31 — FORM 10-Q
- Form 10-K — filed 2016-08-22 — period 2016-05-31 — FORM 10-K
- Form 8-K — filed 2016-05-10 — period 2016-05-04 — FORM 8-K
- Form 10-Q — filed 2016-04-11 — period 2016-02-29 — FORM 10-Q
- Form 10-Q — filed 2016-01-13 — period 2015-11-30 — FORM 10-Q

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/immucor-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology